These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21881985)

  • 1. Low level of seroconversion after a novel influenza A/H1N1/2009 vaccination in Japanese patients with rheumatoid arthritis in the 2009 season.
    Iwamoto M; Homma S; Onishi S; Kamata Y; Nagatani K; Yamagata Z; Minota S
    Rheumatol Int; 2012 Nov; 32(11):3691-4. PubMed ID: 21881985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice.
    Ribeiro AC; Guedes LK; Moraes JC; Saad CG; Aikawa NE; Calich AL; França IL; Carvalho JF; Sampaio-Barros PD; Goncalves CR; Borba EF; Timenetsky Mdo C; Precioso AR; Duarte A; Bonfa E; Laurindo IM
    Ann Rheum Dis; 2011 Dec; 70(12):2144-7. PubMed ID: 21859696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients.
    Ott U; Sauerbrei A; Lange J; Schäfler A; Walther M; Wolf G; Wutzler P; Zell R; Krumbholz A
    Med Microbiol Immunol; 2012 Aug; 201(3):297-302. PubMed ID: 22350187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study.
    Adler S; Krivine A; Weix J; Rozenberg F; Launay O; Huesler J; Guillevin L; Villiger PM
    Rheumatology (Oxford); 2012 Apr; 51(4):695-700. PubMed ID: 22171015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients.
    Chang YT; Guo CY; Tsai MS; Cheng YY; Lin MT; Chen CH; Shen D; Wang JR; Sung JM
    Vaccine; 2012 Jul; 30(33):5009-18. PubMed ID: 22658967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and long-term persistence of immune response following two doses of an AS03A-adjuvanted H1N1 influenza vaccine in healthy Japanese adults.
    Ikematsu H; Nagai H; Kawashima M; Kawakami Y; Tenjinbaru K; Li P; Walravens K; Gillard P; Roman F
    Hum Vaccin Immunother; 2012 Feb; 8(2):260-6. PubMed ID: 22426369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
    Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
    Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody persistence after Pandemic H1N1 2009 influenza vaccination among healthcare workers in Pune, India.
    Tandale BV; Pawar SD; Gurav YK; Parkhi SS; Mishra AC
    Hum Vaccin Immunother; 2013 Jan; 9(1):125-7. PubMed ID: 23047369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial.
    Park JK; Lee YJ; Shin K; Ha YJ; Lee EY; Song YW; Choi Y; Winthrop KL; Lee EB
    Ann Rheum Dis; 2018 Jun; 77(6):898-904. PubMed ID: 29572291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients.
    Fairhead T; Hendren E; Tinckam K; Rose C; Sherlock CH; Shi L; Crowcroft NS; Gubbay JB; Landsberg D; Knoll G; Gill J; Kumar D
    Transpl Infect Dis; 2012 Dec; 14(6):575-83. PubMed ID: 22999005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
    Maruszak H; Jeganathan S; Smith DE; Robertson P; Barnes T; Furner V
    HIV Med; 2012 Jul; 13(6):352-7. PubMed ID: 22296264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to 2009 pandemic H1N1 influenza virus A monovalent vaccine in children with cancer.
    Yen TY; Jou ST; Yang YL; Chang HH; Lu MY; Lin DT; Lin KH; Huang LM; Chang LY
    Pediatr Blood Cancer; 2011 Dec; 57(7):1154-8. PubMed ID: 21425448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate and lower graft function reduce the seroresponse of kidney transplant recipients to pandemic H1N1 vaccination.
    Mulley WR; Visvanathan K; Hurt AC; Brown FG; Polkinghorne KR; Mastorakos T; Lewicki MC; Stuart RL; Tan SJ; Chean R; Kerr PG; Kanellis J
    Kidney Int; 2012 Jul; 82(2):212-9. PubMed ID: 22495292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar immunogenicity of the A/H1N1 2009 pandemic influenza strain when used as a monovalent or a trivalent vaccine.
    Van der Vliet D; Pepin S; Lambert M; Fauchoux N; Donazzolo Y; Dupuy M; Dakowski C; Denis M
    Hum Vaccin; 2010 Oct; 6(10):823-8. PubMed ID: 20935517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term immunogenicity of the pandemic influenza A/H1N1 2009 vaccine among health care workers: influence of prior seasonal influenza vaccination.
    Song JY; Cheong HJ; Seo YB; Kim IS; Noh JY; Choi WS; Lee J; Jeong HW; Kee SY; Kim WJ
    Clin Vaccine Immunol; 2013 Apr; 20(4):513-6. PubMed ID: 23365206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.
    McVernon J; Laurie K; Barr I; Kelso A; Skeljo M; Nolan T
    Influenza Other Respir Viruses; 2011 Jan; 5(1):7-11. PubMed ID: 21138535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic.
    Skowronski DM; Hottes TS; Janjua NZ; Purych D; Sabaiduc S; Chan T; De Serres G; Gardy J; McElhaney JE; Patrick DM; Petric M
    CMAJ; 2010 Nov; 182(17):1851-6. PubMed ID: 20956500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host.
    de Lavallade H; Garland P; Sekine T; Hoschler K; Marin D; Stringaris K; Loucaides E; Howe K; Szydlo R; Kanfer E; Macdonald D; Kelleher P; Cooper N; Khoder A; Gabriel IH; Milojkovic D; Pavlu J; Goldman JM; Apperley JF; Rezvani K
    Haematologica; 2011 Feb; 96(2):307-14. PubMed ID: 20971824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF blockers show distinct patterns of immune response to the pandemic influenza A H1N1 vaccine in inflammatory arthritis patients.
    França IL; Ribeiro AC; Aikawa NE; Saad CG; Moraes JC; Goldstein-Schainberg C; Laurindo IM; Precioso AR; Ishida MA; Sartori AM; Silva CA; Bonfa E
    Rheumatology (Oxford); 2012 Nov; 51(11):2091-8. PubMed ID: 22908326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.